Eder Martins
Vice President, Head of Lung Cancer Franchise, US Oncology Business Unit
Responsibilities
Eder Martins, Vice President, Head of Lung Cancer Franchise, US Oncology Business Unit, is responsible for overseeing all lung cancer US sales and the commercialization of TAGRISSO, DATROWAY, and future lung cancer assets and indications.
Prior Experience
Before assuming his current role in 2026, Eder held senior leadership roles across oncology and specialty care spanning clinical research, medical affairs, and commercial. Most recently, he led US marketing for lung cancer and the ADC/TDR portfolios. Previously, he was Head of Oncology in AstraZeneca Brazil and held multiple leadership roles at other large pharmaceutical companies, including large experience in Oncology and Hematology markets.
Education
- MBA, Marketing, Fundação Getulio Vargas
- Bachelor of Pharmacy, Universidade de São Paulo
Our leadership, which includes our Board of Directors and Senior Executive Team represents the interests of all our stakeholders in ensuring that we deliver for patients by putting science at the heart of everything we do.
Stories from our people and our partners reveal the passion, energy and knowledge that enable us to put science at the heart of everything we do.
We are a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
Join AstraZeneca
and help us deliver life-changing medicines
Be among our employees who continue to make us an innovation-driven company that stands firmly among the world’s leaders in biopharmaceuticals.
Use a maximum of two downloads here